ホーム › 大腸癌 › ペンシルベニア

ペンシルベニアにおける大腸癌の臨床試験

ペンシルベニア内の拠点で、大腸癌に関する69件の研究が参加者を募集しています。

ペンシルベニア内の都市

公式研究テキスト（英語）

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Christiana Care Health System-Concord Health Center, Chadds Ford
Geisinger Medical Center, Danville
Penn State Milton S Hershey Medical Center, Hershey
他4件

被験者募集中第2相

18歳以上 · 全性別 · 2026/10/02更新 · NCT05673148

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Abramson Cancer Center of the University of Pennsylvania, Philadelphia
University of Pittsburgh Medical Center, Pittsburgh
WellSpan York Cancer Center, York

被験者募集中第1/2相

12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Geisinger Medical Center, Danville
他7件

被験者募集中観察研究健康なボランティア歓迎

40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

Family Communications After Genetic Testing

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Pocono Medical Center, East Stroudsburg
他2件

被験者募集中健康なボランティア歓迎

18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #104, Hershey
Exelixis Clinical Site #98, Philadelphia
Exelixis Clinical Site #32, Pittsburgh

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Penn State Milton S. Hershey Medical Center, Hershey

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/30更新 · NCT06324357

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, Pittsburgh

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/29更新 · NCT05877599

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

UPMC Hillman Cancer Center, Pittsburgh

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/29更新 · NCT05803382

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

University of Pittsburgh Medical Center (UPMC), Pittsburgh

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/28更新 · NCT05482893

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

GSK Investigational Site, Philadelphia

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/25更新 · NCT07277270

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Research Site, Philadelphia
Research Site, Pittsburgh

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06218914

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Alliance Cancer Specialists at Main Line, Penn Wynne
Thomas Jefferson University, Philadelphia
Fox Chase Cancer Center, Philadelphia
他1件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06750094

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Thomas Jefferson University, Philadelphia
Fox Chase Cancer Center, Philadelphia
University Of Pittsburgh Medical Center UPMC Hillman Cancer Center, Pittsburgh

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06662786

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Lehigh Valley Hospital-Cedar Crest, Allentown
Saint Vincent Hospital, Erie
Jefferson Hospital, Jefferson Hills
他5件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/24更新 · NCT05863195

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Lehigh Valley Health Network, Allentown
Local Institution - 0604, Pittsburgh

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/09/23更新 · NCT07221357

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Allegheny Health Network, Pittsburgh

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

University of Pittsburgh Medical Center, Pittsburgh

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07114601

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Hospital of the University of Pennsylvania, Philadelphia

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/22更新 · NCT06445062

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

University of Pennsylvania, Philadelphia
Fox Chase Cancer Center, Philadelphia

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07213791

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Alliance Cancer Specialists, Doylestown
Penn State Milton S. Hershey Medical Center, Hershey
University of Pennsylvania, Philadelphia
他3件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/15更新 · NCT07284849

SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors

UPMC Hillman Cancer Center, Pittsburgh

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/10更新 · NCT07812805

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Clinical Study Site, Lebanon
Clinical Study Site, Philadelphia
Clinical Study Site, Philadelphia
他4件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/08更新 · NCT07228832

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/02更新 · NCT07216105

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

UPenn Lancaster-Ann B. Barshinger Cancer Institute, Lancaster
Thomas Jefferson University - Sidney Kimmel Comprehensive Cancer Center, Philadelphia
UPMC / University of Pittsburgh Medical Center, Pittsburgh

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/01更新 · NCT06992258

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Children's Hospital of Philadelphia, Philadelphia
Children's Hospital of Pittsburgh of UPMC, Pittsburgh

被験者募集中第1/2相

12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center, Pittsburgh

被験者募集中第1相

18歳以上 · 全性別 · 2026/08/24更新 · NCT06586515

A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

UPMC Hillman Cancer Center, Pittsburgh

被験者募集中第2相

18歳以上 · 全性別 · 2026/08/20更新 · NCT07235293

Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients

University of Pennsylvania, Philadelphia

被験者募集中観察研究

18歳以上 · 全性別 · 2026/08/18更新 · NCT05410977

FOG-001 in Locally Advanced or Metastatic Solid Tumors

University of Pennsylvania, Perelman School of Medicine, Philadelphia
University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/08/17更新 · NCT05919264

TCR1188-ABC Cells in KRAS-mutated Cancers

University of Pennsylvania, Philadelphia

被験者募集中第1相

18歳以上 · 全性別 · 2026/08/06更新 · NCT07594067

Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy

PennState Health - Milton S. Hershey Medical Center, Hershey

被験者募集中健康なボランティア歓迎

19歳〜80歳 · 全性別 · 2026/08/05更新 · NCT05826743

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

UPMC Hillman Cancer Center, Pittsburgh

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/07/31更新 · NCT05691491

Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer

UPMC Hillman Cancer Center, Pittsburgh

被験者募集中第1相

18歳以上 · 全性別 · 2026/07/31更新 · NCT06654037

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

Thomas Jefferson University, Philadelphia

被験者募集中第1相

18歳以上 · 全性別 · 2026/07/30更新 · NCT07094113

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

University of Pennsylvania / Abramson Cancer Center, Philadelphia
Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068